Related Experiment Video

Updated: Aug 9, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Nonviral delivery of cancer genetic vaccines

Steven R Little1, Robert Langer

  • 1Department of Chemical Engineering and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02142, USA.

Advances in Biochemical Engineering/Biotechnology
|March 30, 2006
PubMed

Insights

Genetic vaccines offer promise for cancer treatment. Advances in nonviral DNA delivery are key to harnessing the immune system for effective cancer therapy.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Genetic vaccines show potential for treating cancer and other diseases.
  • Nonviral delivery of antigen-encoded plasmid DNA is a key area of research.
  • Understanding dendritic cell immunobiology and immune activation is crucial for vaccine development.

Purpose of the Study:

  • To review advances in nonviral delivery of genetic vaccines for cancer treatment.
  • To discuss delivery technologies and targeting strategies for enhancing vaccine potency.
  • To explore future implications for genetic vaccine development.

Main Methods:

  • Review of current literature on nonviral delivery systems for genetic vaccines.
  • Discussion of dendritic cell immunobiology and immune activation mechanisms.
  • Analysis of targeting strategies to improve vaccine efficacy.

Main Results:

  • Several promising nonviral delivery techniques for genetic vaccines are identified.
  • Targeting strategies are discussed for enhancing the potency of vaccine formulations.
  • The review highlights the progress and challenges in the field of cancer genetic vaccines.

Conclusions:

  • Nonviral delivery technologies are critical for realizing the potential of genetic vaccines in cancer therapy.
  • Further research into delivery and targeting strategies is needed to improve vaccine efficacy.
  • Genetic vaccines hold significant promise for future cancer treatment paradigms.

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...